相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
S. K. Aurora et al.
CEPHALALGIA (2010)
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
H. C. Diener et al.
CEPHALALGIA (2010)
Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program
Andrew Blumenfeld et al.
HEADACHE (2010)
OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
David W. Dodick et al.
HEADACHE (2010)
Minimal important differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) version 2.1
J. C. Cole et al.
CEPHALALGIA (2009)
Early versus delayed initiation of entacapone in levodopa-treated patients with Parkinson's disease: a long-term, retrospective analysis
H. Nissinen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study
Julie Munakata et al.
HEADACHE (2009)
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial
Ludwig Kappos et al.
LANCET NEUROLOGY (2009)
Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin
Parisa Gazerani et al.
PAIN (2009)
Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations
Robert H. Dworkin et al.
PAIN (2009)
Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain
Daniele Ranoux et al.
ANNALS OF NEUROLOGY (2008)
Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults
S. Silberstein et al.
CEPHALALGIA (2008)
The importance of placebo in headache research
H-C Diener et al.
CEPHALALGIA (2008)
Placebo response in the prophylaxis of migraine: A meta-analysis
Ana Macedo et al.
EUROPEAN JOURNAL OF PAIN (2008)
Clinical comparisons of botulinum neurotoxin formulations
Allison Brashear
NEUROLOGIST (2008)
Chronic migraine in the population - Burden, diagnosis, and satisfaction with treatment
Marcelo E. Bigal et al.
NEUROLOGY (2008)
Botulinum neurotoxins in the treatment of refractory pain
Bahman Jabbari
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
The impact of topiramate on health-related quality of life indicators in chronic migraine
David W. Dodick et al.
HEADACHE (2007)
Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study
H-C Diener et al.
CEPHALALGIA (2007)
Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double-blind, placebo-controlled trial
Stephen D. Silberstein et al.
HEADACHE (2007)
The prophylactic treatment of chronic daily headache
Ninan T. Mathew
HEADACHE (2006)
New appendix criteria open for a broader concept of chronic migraine
J Olesen et al.
CEPHALALGIA (2006)
The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization
Parisa Gazerani et al.
PAIN (2006)
Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study
G Bussone et al.
NEUROLOGICAL SCIENCES (2006)
Four methods of estimating the minimal important difference score were compared to establish a clinically significant change in Headache Impact Test
RR Coeytaux et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2006)
Sham device versus inert pill: randomised controlled trial of two placebo treatments
TJ Kaptchuk et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Clinical practice - Chronic daily headache
DW Dodick
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Botulinum toxin type A for the treatment of migraine
Sheena Aurora
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A
KR Aoki
NEUROTOXICOLOGY (2005)
Botulinum toxin type A for the prophylactic treatment of chronic daily headache: A randomized, double-blind, placebo-controlled trial
SD Silberstein et al.
MAYO CLINIC PROCEEDINGS (2005)
Botulinum toxin type A (BOTOX®) for the prophylactic treatment of chronic daily headache:: A randomized, double-blind, placebo-controlled trial
NT Mathew et al.
HEADACHE (2005)
Safety of botulinum toxin type A: a systematic review and meta-analysis
M Naumann et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: Implications for migraine therapy
PL Durham et al.
HEADACHE (2004)
Subcutaneous administration of botulinum toxin A reduces formalin-induced pain
ML Cui et al.
PAIN (2004)
Gabapentin in the prophylaxis of chronic daily headache - A randomized, placebo-controlled study
PJ Spira et al.
NEUROLOGY (2003)
Topiramate in the treatment of chronic migraine
M Silvestrini et al.
CEPHALALGIA (2003)
Assessment of migraine disability using the Migraine Disability Assessment (MIDAS) Questionnaire: A comparison of chronic migraine with episodic migraine
ME Bigal et al.
HEADACHE (2003)
Chronic daily headache prophylaxis with tizanidine: A double-blind, placebo-controlled, multicenter outcome study
JR Saper et al.
HEADACHE (2002)
Prevalence and burden of migraine in the United States: Data from the American Migraine Study II
RB Lipton et al.
HEADACHE (2001)
Quality-of-life differences between patients with episodic and transformed migraine
DM Meletiche et al.
HEADACHE (2001)
Botulinum toxin A and chronic low back pain - A randomized, double-blind study
L Foster et al.
NEUROLOGY (2001)
Management of spasticity associated pain with botulinum toxin A
J Wissel et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2000)
Botulinum toxin type A as a migraine preventive treatment
S Silberstein et al.
HEADACHE (2000)
Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: Involvement of two distinct mechanisms
J Purkiss et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins
MJ Welch et al.
TOXICON (2000)
Treatment of chronic cervical-associated headache with botulinum toxin A: A pilot study
BJ Freund et al.
HEADACHE (2000)
分享论文
